Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men

Neuropsychopharmacology

Volumn 31, Issue 3, 2006, Pages 659-674

  Evans, Suzette M ^a,b   Foltin, Richard W ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia University ^*  (United States)

Author keywords

Cocaine; Humans; Menstrual cycle; Progesterone; Sex differences; Subjective effects

Indexed keywords

COCAINE; CONJUGATED ESTROGEN; PLACEBO; PROGESTERONE;

ADULT; ARTICLE; BLOOD PRESSURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; FEMALE; FOLLICULAR PHASE; HEART RATE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HUMAN EXPERIMENT; LUTEAL PHASE; MALE; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; SMOKING; TIME;

ADULT; BLOOD PRESSURE; COCAINE; COCAINE-RELATED DISORDERS; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; FOLLICULAR PHASE; HEART RATE; HUMANS; LUTEAL PHASE; MALE; MENSTRUAL CYCLE; MOTIVATION; PROGESTERONE; SEX CHARACTERISTICS;

EID: 33244470338     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300887     Document Type: Article

References (88)

1. Anderson KG, van Haaren F (1999). Cocaine discrimination and time-course effects in male and female Wistar rats. Eur J Pharmacol 382: 69-74.
2. Anderson KG, van Haaren F (2000). Effects of SCH-23390 and raclopride on cocaine discrimination in male and female Wistar rats. Pharmacol Biochem Behav 65: 671-675.
3. Becker JB, Cha J-H (1989). Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis. Behav Brain Res 35: 117-125.
4. Becker JB, Robinson TE, Lorenz KA (1982). Sex differences and estrous cycle variations in amphetamine-elicited rotational behavior. Eur J Pharmacol 80: 65-72.
5. Bowman BP, Vaughan SR, Walker QD, Davis SL, Little PJ, Scheffler NM et al (1999). Effects of sex and gonadectomy on cocaine metabolism in the rat. J Pharmacol Exp Ther 290: 1316-1323.
6. A receptor function. Pharm Biochem Behav 45: 423-428.
7. Butcher RL, Collins WE, Fugo NW (1974). Plasma concentrations of LH, FSH, prolactin, progesterone and estradiol-17β throughout the 4-day estrous cycle of the rat. Endocrinology 94: 1704-1708.
8. Caine SB, Bowen CA, Yu G, Zuzga D, Negus SS, Mello NK (2004). Effect of gonadectomy and gonadal hormone replacement on cocaine self-administration in female and male rats. Neuropsychopharmacology 29: 929-942.
9. Camp DM, Becker JB, Robinson TE (1986). Sex differences in the effects of gonadectomy on amphetamine-induced rotational behavior in rats. Behav Neural Biol 46: 491-495.
10. Carroll ME, Lynch WJ, Roth ME, Morgan AD, Cosgrove KP (2004). Sex and estrogen influence drug abuse. Trends Pharmacol Sci 25: 273-279.
11. Castner SA, Xiao L, Becker JB (1993). Sex differences in striatal dopamine: in vivo microdialysis and behavioral studies. Brain Res 610: 127-134.
12. Craft RM, Stratmann JA (1996). Discriminative stimulus effects of cocaine in female versus male rats. Drug Alcohol Depend 42: 27-37.
13. de Lignieres B (1999). Oral micronized progesterone. Clin Ther 21: 41-60.
14. de Wit H, Schmitt L, Purdy R, Hauger R (2001). Effects of acute progesterone administration in healthy postmenopausal women and normally-cycling women. Psychoneuroendocrinology 26: 697-710.
15. Diaz-Veliz G, Baeza R, Benavente F, Dussaubat N, Mora S (1994). Influence of the estrous cycle and estradiol on the behavioral effects of amphetamine and apomorphine in rats. Pharmacol Biochem Behav 49: 819-825.
16. Dluzen DE, Ramirez VD (1987). Intermittent infusion of progesterone potentiates whereas continuous infusion reduces amphetamine-stimulated dopamine release from ovariectomized estrogen-primed rat striatal fragments superfused in vitro. Brain Res 406: 1-9.
17. Dluzen DE, Ramirez VD (1989). Progesterone enhances L-dopastimulated release from the caudate nucleus of freely behaving ovariectomized-estrogen- primed rats. Brain Res 494: 122-128.
18. Dluzen DE, Ramirez VD (1990a). In vitro progesterone modulation of amphetamine-stimulated dopamine release from the corpus striatum of ovariectomized estrogen-treated female rats: response characteristics. Brain Res 517: 117-122.
19. Dluzen DE, Ramirez VD (1990b). In vitro progesterone modulates amphetamine-stimulated dopamine release from the corpus striatum of castrated male rats treated with estrogen. Neuroendocrinology 52: 517-520.
20. Eikelis N, van den Buuse M (2000). Cardiovascular responses to open-field stress in rats: sex differences and effects of gonadal hormones. Stress 3: 319-334.
21. Evans SM, Foltin RW (2004). Pharmacokinetics of intravenous cocaine across the menstrual cycle in rhesus monkeys. Neuropsychopharmacology 29: 1889-1900.
22. Evans SM, Haney M, Fischman MW, Foltin RW (1999). Limited sex differences in response to binge smoked cocaine use in humans. Neuropsychopharmacology 21: 445-454.
23. Evans SM, Haney M, Foltin RW (2002). The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology 159: 397-406.
24. Festa ED, Quiñones-Jenab V (2004). Gonadal hormones provide the biological basis for sex differences in behavioral responses to cocaine. Horm Behav 46: 509-519.
25. First MB, Spitzer RL, Gibbon M, Williams JBW (1994). Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, version 2.0). Biometrics Research Department, New York State Psychiatric Institute.
26. Fitzpatrick LA, Good A (1999). Micronized progesterone: clinical indications and comparison with current treatments. Fertil Steril 72: 389-397.
27. Foltin RW, Fischman MW, Nestadt G, Stromberger H, Cornell EE, Pearlson GD (1990). Demonstration of naturalistic methods for cocaine smoking by human volunteers. Drug Alcohol Depend 26: 145-154.
28. Freeman EW, Purdy RH, Coutifaris C, Rickels K, Paul SM (1993). Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers. Neuroendocrinology 58: 478-484.
29. Freeman EW, Weinstock L, Rickels K, Sondheimer SJ, Coutifaris C (1992). A placebo-controlled study of effects of oral progesterone on performance and mood. Br J Clin Pharmacol 33: 293-298.
30. Grimm J, See RE (1997). Cocaine self-administration in ovariectomized rats is predicted by response to novelty, attenuated by 17-B estradiol, and associated with abnormal vaginal cytology. Physiol Behav 61: 755-761.
31. Grön G, Friess E, Herpers M, Rupprecht R (1997). Assessment of cognitive performance after progesterone administration in healthy male volunteers. Neuropsychobiology 35: 147-151.
32. Haney M, Castanon N, Cador M, Le Moal M, Mormede P (1994). Cocaine sensitivity in roman high and low avoidance rats is modulated by sex and gonadal hormone status. Brain Res 645: 179-185.
33. Haney M, Collins ED, Ward AS, Foltin RW, Fischman MW (1999). Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans. Psychopharmacology 143: 102-110.
34. Haney M, Foltin RW, Fischman MW (1998). Effects of pergolide on intravenous cocaine self-administration in men and women. Psychopharmacology 137: 15-24.
35. Hecht GS, Spear NE, Spear LP (1999). Changes in progressive ratio responding for intravenous cocaine throughout the reproductive process in female rats. Dev Psychobiol 35: 136-145.
36. Honisett SY, Pang B, Stojanovska L, Sudhir K, Komesaroff PA (2003). Progesterone does not influence vascular function in postmenopausal women. J Hypertens 21: 1145-1149.
37. Hu M, Becker JB (2003). Effects of sex and estrogen on behavioral sensitization to cocaine in rats. J Neurosci 23: 693-699.
38. Hu M, Crombag HS, Robinson TE, Becker JB (2004). Biological basis of sex differences in the propensity to self-administer cocaine. Neuropsychopharmacology 29: 81-85.
39. Justice AJH, de Wit H (1999). Acute effects of d-amphetamine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology 145: 67-75.
40. Justice AJH, de Wit H (2000a). Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women. Pharmacol Biochem Behav 66: 509-515.
41. Justice AJH, de Wit H (2000b). Acute effects of estradiol pretreatment on the response to d-amphetamine in women. Neuroendocrinology 71: 51-59.
42. Kosten TR, Kosten TA, McDougle CJ, Hameedi FA, McCance EF, Rosen MI et al (1996). Gender differences in response to intranasal cocaine administration to humans. Biol Psychiatry 39: 147-148.
43. Liao QP, Buhimschi IA, Saade G, Chwalisz K, Garfield RE (1996). Regulation of vascular adaptation during pregnancy and post-partum: effects of nitric oxide inhibition and steroid hormones. Hum Reprod 11: 2777-2784.
44. Little BC, Matta RJ, Zahn TP (1974). Physiological and psychological effects of progesterone in man. J Nerv Ment Dis 159: 256-262.
45. Lukas SE, Sholar M, Hundahl LH, Lamas X, Kouri E, Wines JD et al (1996). Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology 125: 346-354.
46. Lynch WJ, Arizzi MN, Carroll ME (2000). Effects of sex and the estrous cycle on regulation of intravenously self-administered cocaine in rats. Psychopharmacology 152: 132-139.
47. Lynch WJ, Roth ME, Mickelberg JL, Carroll ME (2001). Role of estrogen in the acquisition of intravenously self-administered cocaine in female rats. Pharmacol Biochem Behav 68: 641-646.
48. Lynch WJ, Roth MN, Carroll ME (2002). Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology 164: 121-137.
49. Manhem K, Jern S (1994). Influence of daily-life activation on pulse rate and blood pressure changes during the menstrual cycle. J Hum Hypertens 8: 851-856.
50. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, et al, Women's Health Initiative Investigators (2003). Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349: 523-534.
51. Martini MC, Lampe JW, Slavin JL, Kurzer MS (1994). Effect of the menstrual cycle on energy and nutrient intake. Am J Clin Nutr 60: 895-899.
52. Matthews KA, Owens JF, Salomon K, Harris KF, Berga SL (2005). Influence of hormone therapy on the cardiovascular responses to stress of postmenopausal women. Biol Psychol 69: 39-56.
53. Maxson WS, Hargrove JT (1985). Bioavailability of oral micronized progesterone. Fertil Steril 44: 622-626.
54. Mello NK, Bowen CA, Mendelson JH (2002). Comparison of plasma cocaine levels during a 'binge' pattern of cocaine administration in male and female rhesus monkeys. Psychopharmacology 164: 19-26.
55. Mello NK, Mendelson JH (2002). Cocaine, hormones, and behavior: clinical and preclinical studies. Hormones Brain Behav 5: 665-745.
56. Mello NK, Mendelson JH, Kelly M, Bowen C (2000). The effects of cocaine on basal and human chorionic gonadotropin-stimulated ovarian steroid hormones in female rhesus monkeys. J Pharmacol Exp Ther 294: 1137-1145.
57. Mendelson JH, Mello NK, Sholar MB, Siegel AJ, Kaufman MJ, Levin JM et al (1999). Cocaine pharmacokinetics in men and in women during the follicular and luteal phases of the menstrual cycle. Neuropsychopharmacology 21: 294-303.
58. Michanek A, Meyerson BJ (1982). Influence of estrogen and progesterone on behavioral effects of apomorphine and amphetamine. Pharmacol Biochem Behav 16: 875-879.
59. Moran VH, Leathard HL, Coley J (2000). Cardiovascular functioning during the menstrual cycle. Clin Physiol 20: 496-504.
60. Niyomchai T, Russo SJ, Festa ED, Akhavan A, Jenab S, Quiñones-Jenab V (2005). Progesterone inhibits behavioral responses and estrogen increases corticosterone levels after acute cocaine administration. Pharmacol Biochem Behav 80: 603-610.
61. Paul SM, Purdy RH (1992). Neuroactive steroids. FASEB J 6: 2311-2322.
62. Pecins-Thompson M, Keller-Wood M (1997). Effects of progesterone on blood pressure, plasma volume, and responses to hypotension. Am J Physiol 272: 377-385.
63. Perotti LI, Russo SJ, Fletcher H, Chin J, Webb T, Jenab S et al (2001). Ovarian hormones modulate cocaine-induced locomotor and stereotypic activity. Ann NY Acad Sci 937: 202-216.
64. Petitclerc M, Bedard PJ, DiPaolo T (1995). Progesterone releases dopamine in male and female rat striatum: a behavioral and microdialysis study. Prog Neuro-Psychopharm Behav Psychiatry 19: 491-497.
65. Plessinger MA, Woods Jr JR (1990). Progesterone increases cardiovascular toxicity to cocaine in nonpregnant ewes. Am J Obstet Gynecol 163: 1659-1664.
66. Quiñones-Jenab V, Ho A, Schlussman SD, Franck J, Kreek MJ (1999). Estrous cycle differences in cocaine-induced stereotypic and locomotor behaviors in Fischer rats. Behav Brain Res 101: 15-20.
67. Quiñones-Jenab V, Perrotti LI, Mc Monagle J, Ho A, Kreek MJ (2000). Ovarian hormone replacement affects cocaine-induced behaviors in ovariectomized female rats. Pharmacol Biochem Behav 67: 417-422.
68. Reddy DS, O'Malley BW, Rogawski MA (2005). Anxiolytic activity of progesterone in progesterone receptor knockout mice. Neuropharmacology 48: 14-24.
69. Roberts DCS, Bennett SAL, Vickers GJ (1989). The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology 98: 408-411.
70. Roberts DCS, Dalton JCH, Vickers GJ (1987). Increased self-administration of cocaine following haloperidol: effect of ovariectomy, estrogen replacement, and estrous cycle. Pharmacol Biochem Behav 26: 37-43.
71. Russo SJ, Festa ED, Fabian SJ, Gazi FM, Kraisch M, Jenab S et al (2003). Gonadal hormones differentially modulate cocaine-induced place preference in male and female rats. Neuroscience 120: 523-533.
72. Rylance PB, Brincat M, Lafferty K, de Trafford JC, Brincat S, Parsons V et al (1985). Natural progesterone and antihypertensive action. Br Med J 290: 13-14.
73. Sell SL, Scalzitti JM, Thomas ML, Cunningham KA (2000). Influence of ovarian hormones and estrous cycle on the behavioral responses to cocaine in female rats. J Pharmacol Exp Ther 293: 879-886.
74. Shangold MM, Tomai TP, Cook JD, Jacobs SL, Zinaman MJ, Chin SY et al (1991). Factors associated with withdrawal bleeding after administration of oral micronized progesterone in women with secondary amenorrhea. Fertil Steril 56: 1040-1047.
75. Sharma A, Plessinger MA, Miller RK, Woods Jr JR (1993). Progesterone antagonist mifepristone (RU 486) decreases cardiotoxicity of cocaine. Proc Soc Exp Biol Med 202: 279-287.
76. Sharma A, Plessinger MA, Sherer DM, Liang C-S, Miller RK, Woods Jr JR (1992). Pregnancy enhances cardiotoxicity of cocaine: role of progesterone. Toxicol Appl Pharmacol 113: 30-35.
77. Shimizu H, Bray GA (1993). Effects of castration, estrogen replacement and estrus cycle on monoamine metabolism in the nucleus accumbens, measured by microdialysis. Brain Res 621: 200-206.
78. Simon JA, Robinson DE, Andrews MC, Hildebrand III JR, Rocci Jr ML, Blake RE et al (1993). The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone. Fertil Steril 60: 26-33.
79. Sircar R, Kim D (1999). Female gonadal hormones differentially modulate cocaine-induced behavioral sensitization in Fischer, Lewis, and Sprague-Dawley rats. J Pharmacol Exp Ther 289: 54-65.
80. Smith MS, Freeman ME, Neill JD (1975). The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gondadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Neuroendocrinology 96: 219-226.
81. Söderpalm AH, Lindsey S, Purdy RH, Hauger R, de Wit H (2004). Administration of progesterone produces mild sedative-like effects in men and women. Psychoneuroendocrinology 29: 339-354.
82. Sofuoglu M, Babb DA, Hatsukami DK (2002). Effects of progesterone treatment on smoked cocaine response in women. Pharmacol Biochem Behav 72: 431-435.
83. Sofuoglu M, Dudish-Poulsen S, Nelson D, Pentel PR, Hatsukami DK (1999). Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Exp Clin Psychopharmacol 7: 274-283.
84. Sofuoglu M, Mitchell E, Kosten TR (2004). Effects of progesterone treatment on cocaine responses in male and female cocaine users. Pharmacol Biochem Behav 78: 699-705.
85. Tollan A, Oian P, Kjeldsen SE, Eide I, Maltau JM (1993). Progesterone reduces sympathetic tone without changing blood pressure or fluid balance in men. Gynecol Obstet Invest 36: 234-238.
86. Walsh SL, Haberny KA, Bigelow GE (2000). Modulation of the effects of intravenous cocaine following chronic oral cocaine in humans. Psychopharmacology 150: 361-373.
87. White TL, Justice AJ, de Wit H (2002). Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav 73: 729-741.
88. Woods Jr JR, Plessinger MA (1990). Pregnancy increases cardiovascular toxicity to cocaine. Am J Obstet Gynecol 162: 529-533.